Why the study?
Clinical practice guidelines for soft tissue sarcomas do not always address many practical situations encountered in everyday multidisciplinary specialist care.
This Delphi consensus provides specific recommendations for the multidisciplinary management of soft tissue sarcomas to address gaps in current clinical practice guidelines.
Consensus fills STS guideline gaps; leaves open need for prospective validation before practice change.
Soft tissue sarcomas (STS) constitute a heterogeneous group of rare solid tumors associated with significant morbidity and mortality. The evaluation and treatment of STS require a multidisciplinary team with extensive experience in the management of these types of tumors. National and international clinical practice guidelines for STS do not always provide answers to a great many situations that specialists have to contend with in their everyday practice. This consensus provides a series of specific recommendations based on available scientific evidence and the experience of a group of experts to assist in decision-making by all the specialists involved in the management of STS.
No takes yet. Share an insight, caveat, or question.
Álvarez et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: